19 research outputs found
a. Mean RMS amplitudes of <i>C. elegans</i> L1 from 0 and 100 worms, live and dead.
<p><b>b</b>. FFT of 100 <i>C. elegans</i> L1(blue), overlaid with 100 <i>b. pahangi</i> (black), and blank (red). <b>c</b>. Ratios of selected frequency ranges of <i>C. elegans</i> L1 motion, showing significant differences (*) in RMS amplitudes of degraded worms vs blanks (p<0.0001), healthy worms vs blank (p<0.0001), and healthy worms vs degraded in all but the ratio of middle frequency range to high frequency range (p = 0.3095).</p
a. Mean returns (y-axis) for <i>B. pahangi</i> microfilariae from 0–1500 worms (x-axis) per tube.
<p>(*) shows significant difference between 300mf and blank using Tukey’s test (p = 0.0079), <b>b</b>. Mean returns for 5000 live microfilariae, 5000 dead microfilariae, and 5000 live & dead. <b>c</b>. Mean returns for 100 live microfilariae, 100 dead microfilariae, and 100 live & dead. <b>d</b>. 500 live microfilariae, 500 dead microfilariae, and 500 live & dead microfilariae.</p
a. Mean RMS amplitudes for live and dead adult male and female <i>B. pahangi</i>.
<p><b>b</b>. Mean RMS amplitudes for adult females treated with different molar concentrations of imatinib mesylate, (*) significant differences from before drug treatment at 1hpt and on (p<0.0291). <b>c</b>. Mean RMS amplitudes for adult females treated with different molar concentrations of chloroquine significant differences from before drug treatment at 1hpt and on (p<0.0346).</p
a. Mean RMS amplitudes for blank and 100 live and dead <i>B. pahangi</i> L3’s.
<p><b>b</b>. Mean RMS amplitudes over time of L3’s treated at different molar concentrations of imatinib mesylate, (*) significant change from pretreatment earlier than control or other groups (p = 0.0153). <b>c</b>. Mean RMS amplitudes of L3’s treated at different molar concentrations of chloroquine, (*) significant change from pretreatment earlier than control or other groups (p<0.0001). <b>d</b>. Ratios of the maximum amplitudes for the selected frequency ranges of L3 motion, healthy (*) significantly different from blank or degraded (all p<0.0001), blank statistically same as degraded (all p>0.1917)</p
Trip duration by filarial infection among nonendemic visitors
<p>Trip duration by filarial infection among nonendemic visitors</p
Region and countries of exposure to filarial parasite
<p>Region and countries of exposure to filarial parasite</p
Regional distribution of filarial infections among immigrants, VFR, and nonendemic visitors reported in the GeoSentinel Surveillance Network.
<p>Regional distribution of filarial infections among immigrants, VFR, and nonendemic visitors reported in the GeoSentinel Surveillance Network.</p
Association between patient endemicity status and commonly presenting symptoms of filarial infections
<p>Association between patient endemicity status and commonly presenting symptoms of filarial infections</p
Reason for travel among persons with filarial infections reported in the GeoSentinel Surveillance Network.
<p>Reason for travel among persons with filarial infections reported in the GeoSentinel Surveillance Network.</p
Distribution of filarial infections among international travelers reported in the GeoSentinel Surveillance Network.
<p>Distribution of filarial infections among international travelers reported in the GeoSentinel Surveillance Network.</p